Kraig Biocraft Laboratories, Inc. Income Statement
KBLB|8 years of annual SEC 10-K data (FY2012-FY2019)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 8 fiscal years. All figures from audited SEC 10-K filings.
Revenue has grown at a 255.1% compound annual rate over the past 2 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -50.01 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | $401.6K | $97.3K | $31.9K | $0 | $0 | $0 | $0 |
| SG&A Expense | $1.4M | $515.9K | $1.2M | $1.7M | $920.9K | $896.1K | $1.3M | $379.3K |
| R&D Expense | $223.1K | $148.1K | $258.9K | $397.1K | $432.0K | $439.5K | $489.4K | $465.3K |
| Operating Income | -$2.6M | -$959.9K | -$2.2M | -$2.9M | -$2.1M | -$1.8M | -$2.2M | -$1.6M |
| Interest Expense | $294.4K | $229.0K | $177.1K | $139.4K | $101.5K | $69.3K | $65.6K | $45.7K |
| Income Tax | - | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$2.9M | -$1.2M | -$2.3M | -$3.1M | -$2.1M | -$1.9M | -$7.5M | -$1.6M |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 |
| Shares Outstanding | 816.9M | 791.4M | 744.3M | 708.1M | 674.0M | 635.2M | 596.1M | 572.7M |
| Operating Margin | - | -239.0% | -2215.4% | -9246.0% | - | - | - | - |
| Profit Margin | - | -291.1% | -2397.4% | -9648.6% | - | - | - | - |